Increase of the IL-1β and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH

Neuroendocrinology Letters

Volumn 25, Issue 1-2, 2004, Pages 141-147

  Hendryk, Stanislaw ^a   Jarzab, Barbara ^b   Josko, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

CSF; IL 1 and IL 6 levels; SAH; Vasospasm

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 1;

ANEURYSM; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CONTROLLED STUDY; NEUROLOGIC DISEASE; NONHUMAN; RADIOIMMUNOLOGY; SYMPTOMATOLOGY; VASOSPASM; BRAIN VASOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; INTRACRANIAL ANEURYSM; RANDOMIZED CONTROLLED TRIAL; RUPTURE; SUBARACHNOID HEMORRHAGE; TIME;

BRAIN ISCHEMIA; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTRACRANIAL ANEURYSM; RUPTURE, SPONTANEOUS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VASOSPASM, INTRACRANIAL;

EID: 3242781843     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Mathiesen T, Ender G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-α following subarachnoid hemorrhage. J Neurosurg. 1997; 87:215-20.
2. Kader WE, Krauss ST, Onesti JP, Elliott, Solomon RA. Chronic cerebral blood flow changes following experimental subarachnoid hemorrhage in rats. Stroke 1990; 21(4):577-81.
3. Matsui T, Kaizu H, Itoh S, Asano T. The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. J Neurosurg 1994; 80:276-82 .
4. Matz PG, Massa SM, Weinstein PR, Turner Ch, Panter SS, Sharp FR. Focal hyperexpression of hemeoxygenase-1 protein and messenger RNA in rat brain caused by cellular stress following subarachnoid injections of lysed blood. J Neurosurg 1996; 85:892-903.
5. O'Banion MK, Miller JC, Chang JW, Kaplan MD, Coleman PD. Interleukin-1β induces prostaglandin G/H synthease-2 (cyclooxygenase-2) in primary murine astrocytes cultures. J Neurochem 1996; 66: 2532-40.
6. Suzuki S, Takenaka K, Kassell NF, Lee KS. Hemoglobin augmentation of interleukin-1β induced production of nitric oxide in smooth-muscle cells. J Neurosurg 1994; 81:895-01.
7. Mayberg MR, Okada T, Bark DH. The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neuro- surg 1990; 72:626-33.
8. Nagata K, Sasaki T, Iwama J, Mon T, Ivamoto S, Nirei H, et al. Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in the canine two-hemorrhage model. J Neurosurg 1993; 79:710-15.
9. Nashizawa S, Peterson JW, Shimoyama I, Iwasaki K, Uemura K. Therapeutic effect of new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. Neurosurgery 1993; 32:986-92.
10. Vorkapic P, Bevan RD, Bevan JA. Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery. J Neurosurg 1991; 74:951-5.
11. Pluta RM, Zauner A, Morgan JK, Muraszko KM, Oldfield EH. Is vasospasm related to proliferative arteriopathy? J Neurosurg 1992; 77: 740-8.
12. Kikuchi T, Okuda Y, Kaito N, Abe T. Cytokine production in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res 1995; 17:106-8.
13. De Souza EB, Webster EL, Grigoriadis DE, Tracey DE. Stress, neuroendocrine, and immune relationships. Corticotropin-Releasing Factor (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis. Psychopharmacology bulletin 1989; 25:3 .
14. Schotanus K, Meloen RH, Puijk WC, Berkenbosch F, Binnekade R, Tidlers FJH. Effects of monoclonal antibodies to specific epitopes of rats interleukin-1 beta (IL-1β) on IL-1β-induced ACTH, corticosterone and IL-6 responses in rats. J Neuroendocrinol 1995; 7:255-62.
15. Ryba M, Pastuszko M, Iwanska K., et al. Immunological method for prediction of progress in neurological deficit in patients with intracranial rupture. Acta Neurochir 1989; 97:67-70.
16. Ryba M, Iwanska K, Pastuszko M: Intracranial arterial spasm or arteriospasm syndrome after rupture of intracranial aneurysm? Neur Neurochir Pol 199; 25(3):371-7 .
17. Zuccarello M, Anderson DK. Protective effect of a 21-aminosteroid on the blood brain barrier following subarachnoid hemorrhage in rats. Stroke 1989; 20:367-71.
18. Peterson JW, Nishizawa S, Hackett JD, et al. Cyclosporin A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 1990; 21:133-7.
19. Haly EC, Kassell NF, Apperson C, Stat M, Maile MH, Alves WM, and the Participants. A randomized, double-blind, vehicle-controlled trial of tirilazyd mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 1997; 86: 467-74.
20. Lanzino G, Kassell N, Dorsch NWC, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM, and the Participants: Double-blind, randomized, vehicle-controlled study of high-dose tirilazyd mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 1999; 90:1011-17.
21. Lanzino G, Kassell NF, and the Participants: Double-blind, randomized, vehicle-controlled study of high-dose tirilazyd mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 1999; 90:1018-24.
22. Kimura T, Yamamoto T, Ota K, Shoji M, Inoue M, Sato K, et al. Central effects of interleukin-1 on blood pressure, thermogenesis, and the release of vasopressin, ACTH, and atrial natriuretic peptide. The Neurohypophysis: A window on brain function. Ann NY Ac Sci 1993; 689(22):330-45.
23. Yamamoto T, Kimura T, Ota K, Shoji M, Inoue M, Ohta K, et al. Effects of interleukin-1β on blood pressure, thermoregulation, and the release of vasopressin, ACTH and atrial natriuretic hormone. Tohoku J Exp Med 1994; 173(2):231-45.
24. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α. J Immunol 1992; 149:2358-66 .
25. Giulian D, Baker TJ, Shin LCN, Lachman LB. Interleukin-1 of the central nervous system is produced by amoeboid microglia. J Exp Med 1986; 164:594-601.
26. Malipiero UV, Frei K, Fontana A. Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 1990; 144:3816-21.
27. Van Meir E, Ceska M, Effenberger F, Walz A, Grouzmann E, Desbaillets I, et al. Interleukin-8 produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 1992; 53:4297-305.
28. Sawada M, Kondo N, Suzumura A, Marunouchi Y. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989; 491:394-7.
29. Sawada M, Suzumura A, Marunouchi T. TNF-α induces IL-6 production by astrocytes but not by microglia. Brain Res 1992; 583:296-9 .
30. Hunt WE, Hess RM. Surgical risks as related to time of intervention in the repair of intracranial aneurysm. J Neurosurg 1968; 28:14-20.
31. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6:1-9.
32. Jennett B, Bond M. Assessment of outcome after severe brain damage. A practical scale. Lancet 1975; 1:480-4.
33. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994; 122:135-9.
34. Weir B, Grace M, Hansen J, et al. Time course of vasospasm in man. J Neurosurg 1978; 48:173-8.
35. Mathiesen T, Andersson B, Loftenius A, von Holst H. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993; 78:562-7 .
36. Feuerstein GZ, Liu T, Barone FC. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 1991; 3:336-61.
37. Yabuuchi K, Minami M, Katsumata S, Yamazaki A, Satoh M. An in situ hybridization study on interleukin -1β mRNA induced by transient forebrain ischemia in the rat brain. MoI Brain Res 1994; 26:135-42.
38. Wiedenka DC, Medele RJ, Stummer W, Bise K, Steiger HJ. Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 1999; 90:1098-104.
39. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051-64.
40. Khurana VG, Smith LA, Baker TA, Eguchi D, O'Braien T, Katusic Z. Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 2002; 33:782-92.
41. Sayama T, Suzuki S, Fuki M. Role of inducible nitric oxide synthase in cerebral vasospasm after subarachnoid hemorrhage in rats. Neurol Res 1999; 21:293-298.
42. Quan N, Sundar SK, Weiss JM. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J Neuroimmunol. 1994; 49:125-34.
43. Chao CC, Hu S, Sheng WS, Bu D, Bukrinsky MI, Peterson PK. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. GLIA 1996; 16:276-84 .
44. Pluta RM, Oldfield EH, Boock RJ. Reversaland prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 1997; 87:746-51.
45. Ito Y, Isotani E, Mizuno Y, Azuma H, Hirakawa K. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin. J Cardiovasc Pharmacol 2000; 35:45-50 .
46. Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 1996; 84:648-54.
47. Abbas AK, Lichtman AH, Prober JS. Cellular and molecular immunology. Philadelphia: W.B. Saunders Company 1991: pp. 225-43.
48. May LT, Torcia G, Cozzolino F, Ray A, Tatter SB, Santhanam U, et al. Interleukin-6 gene expression in human endothelin cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun 1989; 160:991-8 .
49. Shalby RM, Waage A, Espevik T. Cytokine regulation of interleukin 6 production by human endothelial cells. Cellular Immunol 1989; 21: 372-82.
50. Calderon TM, Sherman J, Wilkerson H, Hatcher VB, Berman JW. Interleukin 6 modulates c-sis gene expression in cultured human endothelial cells. Cellular Imunnol 1992; 143:118-26 .
51. Gay CG, Winkles JA. Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. J Biol Chem 1990; 265:3284-329.
52. 2 production in cultured bovine vascular release from endothelial cells. Arch Biochem Biophys 1992; 292: 600-4.
53. Kanse SM, Takahashi K, Lam HC, Rees A, Warren JB, Porta M, et al. Cytokine stimulated endothelin release from endothelial cells. Life Science 1991; 48:1379-84.
54. Iwasa K, Bernanke DH, Smith RR, Yamamoto Y. Nonmuscle arterial constriction after subarachnoid hemorrhage: Role of growth factors derived from platelets. Neurosurgery 1993; 32:619-24.
55. Hendryk S, Jarzab B, Latka D, Mrowka R, editors. CRF levels in cerebrospinal fluid in patients with vasospasm after subarachnoid hemor- rhage. Proceedings, of the Congress of Polish Neurosurgeons Society. Lódz, Poland, 29 Sept - 01 Oct, 1994; pp. 25.
56. Hendryk S, Mrówka R, Jarzab B, Jedrzejowska-Szypulka H, Latka D, Josko J. The influence of the cerebral vasospasm following subarachnoid hemorrhage on the β-endorphin concentration in the blood serum and CSF. Neurol Neurochir Pol 1996; 30:suppl 4:453-59.
57. Hendryk S, Josko J, Jedrzejowska-Szypulka H, Jarzab B, Döhler KD. Corticotropin releasing hormone (CRH) increases β-endorphin (β-END like) concentration in cerebrospinal fluid of rats with vasospasm following subarachnoid hemorrhage. J Physiol Pharmacol. 1999; 50(3): 419-28.
58. Rothwell NJ. Central activation of thermogenesis by prostaglandins: Dependence on CRF. Horm Met Res 1990; 22:616-18.
59. Brown MR, Fisher LA, Rivier J, Spiess J, Rivier C, Vale W. Corticotropin-releasing factor: Effects on the sympathetic nervous system and oxygen consumption. Life Sci 1982; 30:207-10.
60. Watanobe H, Takebe K. Intrahypothalamic perfusion with inter-leukin-1β stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rats: a comparative perfusion of the paraventricular nucleus and the median eminence. Neuroendocrinol 1993; 57:593-9.
61. Singh VK, Leu S-JCh. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci Lett 1990; 120:151-4.
62. Heijnen O, Kavelaars A, Ballieux RE. β-Endorphin: Cytokine and neuropeptides. Immunol Rev 1991; 119:41-63.
63. Strieter RM, Kunkel SL, Showell HJ. Endothelial cell gene expression of a neutrophile chemotactic factor by TNFα, LPS, and IL-1β. Science 1989; 243:1467-9.
64. Wong D, Dorovini Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessels endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 1992; 39:11-21.
65. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ. Concomitant cortical expression of TNFα and IL-1β mRNA follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 1994; 23:103-14.
66. Wang X, Siren AL, Liu Y, Yue TL, Barone FC, Feuerstein GZ. Upregulation of intercellular adhesion molecule-1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Brain Res Mol Brain Res 1994; 26:61-8.
67. Katabami T, Shimizu M, Okano K, Yano Y, Nemoto K, Ogura M, et al. Intracellular signal transduction for interleukin-1 β-induced endothelin production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1992; 188:565-70.
68. Barone FC, Globus MY, Price WJ, White RF, Storer BL, Feuerstein GZ, et al. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 1994; 14:337-42.
69. Yamashita K, Kataoka Y, Niwa M, Shigematsu K, Himeno A, Koizumi S, et al. Increased production of endothelins in the hippocampus of stroke-prone spontaneously hypertensive rats following transient forebrain ischemia: histochemical evidence. Cell Mol Neurobiol 1993; 13:15-23.
70. McCarron RM, Wang L, Stanimirovic DB, Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993; 156:31-4.
71. Licinio J, Wong M-L, Gold PhW. Neutrophil-activating peptide-1/ interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. NeuroReport 1992; 3:753-6.
72. Muizelaar JP, Zwienenberg M, Rudisill Na, Hecht ST. The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg 1999; 91: 51-8.
73. Firlik AD, Kaufmann AM, Jungreis ChA, Yonas H. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1997; 86:830-9.
74. Peltonen S, Juvela S, Kaste M, Lassila R. Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg 1997; 87: 207-14.
75. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits. J Neurosurg 1997; 86:594-602